Skip to main content
  • Pleural diseases
  • Open access
  • Published:

The diagnostic utility of pleural fluid viscosity in lymphocytic pleural effusion

Abstract

Context

The first step in the diagnostic work up of pleural effusion is the distinction between transudative and exudative pleural effusions (TPEs and EPEs). This discrimination is based on some biochemical tests that are relatively costly and time consuming. Lymphocyte-predominant EPE is the result of many diseases with malignancy, tuberculosis being the most common among them.

Aims

The aim of this study was to assess the role of pleural fluid viscosity in the differentiation between exudates and transudates and to identify the cause of pleural effusion.

Patients and methods

The study comprised 10 patients with TPE and 48 patients with EPE: 18 of them had tuberculous (TB) effusion, 25 patients had malignant pleural effusion (MPE) (patients with MPE included 10 with lung cancer and 15 with other known or unknown cancers) and five patients had connective tissue disease (CTD)-associated effusion. Pleural fluid protein, albumin, lactic dehydrogenase, and viscosity were measured in all patients.

Results

Pleural fluid viscosity was higher in patients with EPE with a highly significant difference (P < 0.01), and a cutoff value of 1.01 cP could distinguish between TPE and EPE with a sensitivity of 97.7%, a specificity of 93.9%, a positive predictive value of 97.5%, and a negative predictive value of 92.5%. It also showed significant positive correlation with protein, albumin, and lactic dehydrogenase. It was also higher in TB effusion than in MPE, with a highly significant difference (P < 0.01), and in CTD-associated effusion with a significant difference (P < 0.05). At a cutoff value of 1.5 cP, pleural fluid viscosity could discriminate between TB effusion and MPE with a sensitivity of 67%, a specificity of 84%, a positive predictive value of 75%, and a negative predictive value of 77%. There was also a nonsignificant difference between MPE secondary to lung cancer versus other known or unknown primary cancer (P > 0.05).

Conclusion

Pleural fluid viscosity can reliably differentiate between TPE and EPE. It can also help in the discrimination between TB effusion and MPE with moderate sensitivity and high specificity.

References

  1. Diaz-Guzman E, Dweik RA. Diagnosis and management of pleural effusions: a practical approach. Compr Ther 2007; 33:237–246.

    Article  Google Scholar 

  2. Light RW, MacGregor I, Luchsinger PC, Ball WCJr. Pleural effusion: the diagnostic separation of transudates and exudates. Ann Intern Med 1972; 77:507–513.

    Article  CAS  Google Scholar 

  3. Heffner JE, Brown LK, Barbieri C. Diagnostic value of tests that discriminate between exudative and transudative effusions. Chest 1997; 111:970–979.

    Article  CAS  Google Scholar 

  4. Joseph J, Badrinath P, Busron O. Is the pleural fluid transudate or exudate? A re-visit of the diagnostic criteria. Thorax 2001; 56:867–870.

    Article  CAS  Google Scholar 

  5. Ferrer JS, Munoz XG, Orriols RM. Evolution of idiopathic pleural effusion: a prospective, long-term follow-up study. Chest 1996; 109:1508–1513.

    Article  CAS  Google Scholar 

  6. Broaddus VC, Light RW. In: Murray JF, Nadel JA, Mason RJ, Broaddus VC, Martin TR, editors. Pleural effusion. Textbook of respiratory medicine. 5th ed. Philadelphia, USA: Saunders Elsevier 2010. 1719–1759.

    Chapter  Google Scholar 

  7. Yam LT. Diagnostic significance of lymphocytes in pleural effusions. Ann Intern Med 1967; 66:972–982.

    Article  CAS  Google Scholar 

  8. Light RW, Frozan YS, Ball WC. Cells in pleural fluid: their value in differential diagnosis. Arch Intern Med 1973; 132:854–860.

    Article  CAS  Google Scholar 

  9. Lowe GDO. In: Bloom A, Forbes CD, Thomas DP, Tuddenham EGD, editors. Blood rheology, haemostasis and vascular disease. Haemostasis and thrombosis. 2nd ed. Edinburgh: Churchill Livingstone; 1994. 1169–1188.

    Google Scholar 

  10. Yetkin O, Tek I, Kaya A, Ciledag A, Numanoglu N. A simple laboratory measurement for discrimination of transudative and exudative pleural effusion pleural viscosity. Respir Med 2006; 100:1286–1290.

    Article  Google Scholar 

  11. Jain RK. Determinants of tumor blood flow: a review. Cancer Res 1988; 48:2641–2658.

    CAS  PubMed  Google Scholar 

  12. Sakuraba M, Masuda K, Hebisawa A. Pleural effusion adenosine deaminase (ADA) level and occult tuberculous pleurisy. Ann Thorac Cardiovasc Surg 2009; 15:294–296.

    PubMed  Google Scholar 

  13. Aletaha D. Rheumatoid arthritis classification criteria. American College of Rheumatology/European league against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62:2569–2581.

    Article  Google Scholar 

  14. Tan EM. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25:1271–1277.

    Article  CAS  Google Scholar 

  15. Halla JT, Shrohenloher RE, Volanakis JE. Immune complexes and other laboratory features in pleural effusions. Ann Intern Med 1980; 92:748–752.

    Article  CAS  Google Scholar 

  16. Porcel JM, Ordi-Ros J, Esquerda A. Antinuclear antibody testing in pleural fluid for the diagnosis of lupus pleuritis. Lupus 2007; 16:25–27.

    Article  CAS  Google Scholar 

  17. Idris L, Ranaweer N, Laws D. Investigation of pleural effusions. Acute Med 2011; 10:216–220.

    CAS  PubMed  Google Scholar 

  18. Porcel M, Light RW. Diagnostic approach to pleural effusion in adults. Am Fam Physician 2006; 73:1211–1220.

    PubMed  Google Scholar 

  19. Light RW. Clinical practice –pleural effusion. N Engl J Med 2002; 346:1971–1977.

    Article  Google Scholar 

  20. Porcel JM, Vives M, Vicente de vera MC, Cao G, Rubio M, Rivas MC. Useful tests on pleural fluid that distinguish transudates from exudates. Ann Clin Biochem 2001; 38:671–675.

    Article  CAS  Google Scholar 

  21. Romero-candeira S, Fernandez C, Martin C, Sanchez-paya J, Hernandez L. Influence of diuretics on the concentration of proteins and other components of pleural transudates in patients with heart failure. Am J Med 2001; 110:681–686.

    Article  CAS  Google Scholar 

  22. Romero-Candiera S., Hernandez L. The separation of transudates and exudates with particular references to protein gradient. Curr Opin Pulm Med 2004; 10:294–298.

    Article  Google Scholar 

  23. Sam SA, Heffner JG. In: Light RW, Gary Lee YC, editors. Pleural fluid analysis. Textbook of pleural diseases. London: Arnold; 2003. 191–209.

    Google Scholar 

  24. Hurth C, Klein K, van Nimwegen L, Korn R, Vizayaraghavan K, Zenhausern F, et al. Clinical diagnostic of pleural effusions using a high - speed viscosity measurement method. J Appl Phys 2011; 110:701–706.

    Article  Google Scholar 

  25. Reinhart WH. Molecular biology and self- regulatory mechanisms of blood viscosity: a review. Biorheology 2001; 38:203–212.

    CAS  PubMed  Google Scholar 

  26. Kinasewitz ET. In Fishman AP, Elias JA, Fishman JA, Grippi MA, Senior RM, Pack AI, editors. Pleural fluids dynamics and effusions. Fishman’s pulmonary diseases and disorders. 3rd ed. New York: McGraw Hill; 1998. 1389–1410.

    Google Scholar 

  27. Yetkin O, Tek I, Yetkin F, Numanoglu N. Role of pleural viscosity in the differential diagnosis of exudative pleural effusion. Respirology 2007; 12:267–271.

    Article  Google Scholar 

  28. Chang LC, Hua CC, Liu YC, Chu CM, Chen HJ, Lee N. Pleural fluid viscosity may help identify malignant pleural effusions. Respirology 2008; 13:341–345.

    Article  Google Scholar 

  29. Mayse ML. In: Fishman AP, Elias JA, Fishman JA, Grippi MA, Senior RM, Pack AI, editors. Non-malignant pleural effusions. Fishman’s pulmonary diseases and disorders. 4th ed. New York: McGraw Hill; 2008. 1487–1504.

    Google Scholar 

  30. Wang Z, Wang C, Hung X, Shen Y, Shen J, Ying K. Differential proteome profiling of pleural effusions from lung cancer and benign inflammatory disease patients. Biochim Biophys Acta 2012; 182:692–700.

    Article  Google Scholar 

  31. Ji Q, Huang B, Wang M, Ben Z, Zhang S, Zhang Y, et al. Pleural fluid prealbumin and C-reactive protein in the differential diagnosis of infectious and malignant pleural effusions. Exp Ther Med 2014; 7:788–789.

    Google Scholar 

  32. Yetkin O, Tek I, Yetkin F, Numanoglu N. Value of plasma viscosity as an acute phase reactant in patients with pneumonia. Chest 2001; 120:2345.

    Google Scholar 

  33. Nguen MD, Simpson-Haidaris PJ. Cell type-specific fibrinogen expression in lung epithelial cells by dexamethasone and interleukin 1. Ann J Respir Cell Mol Biol 2000; 22:217–219.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sayed Labiba MD.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Labiba, S., Dwidar, I., Riad, E. et al. The diagnostic utility of pleural fluid viscosity in lymphocytic pleural effusion. Egypt J Bronchol 9, 73–78 (2015). https://doi.org/10.4103/1687-8426.153656

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/1687-8426.153656

Keywords